Soleus Capital Management, L.P. Dexcom Inc Transaction History

Soleus Capital Management, L.P.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $3.71 Million - $4.32 Million	33,000 New	33,000 $4.24 Million
Q4 2022 Feb 14, 2023	BUY	$84.98 - $122.67 $1.37 Million - $1.98 Million	16,164 Added 67.81%	40,000 $4.53 Million
Q3 2022 Nov 14, 2022	SELL	$76.35 - $94.18 $1.79 Million - $2.2 Million	-23,400 Reduced 49.54%	23,836 $1.92 Million
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $2.42 Million - $4.73 Million	35,627 Added 306.89%	47,236 $3.52 Million
Q1 2022 May 16, 2022	BUY	$94.08 - $130.2 $362,208 - $501,269	3,850 Added 49.62%	11,609 $5.94 Million
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $1.01 Million - $1.26 Million	7,759 New	7,759 $4.17 Million
Q3 2021 Nov 15, 2021	SELL	$106.71 - $143.18 $627,881 - $842,471	-5,884 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$80.99 - $107.93 $85,120 - $113,434	-1,051 Reduced 15.16%	5,884 $2.51 Million
Q1 2021 May 17, 2021	SELL	$84.79 - $104.74 $104,291 - $128,830	-1,230 Reduced 15.06%	6,935 $2.49 Million
Q4 2020 Feb 16, 2021	BUY	$78.0 - $104.5 $45,396 - $60,819	582 Added 7.68%	8,165 $3.02 Million
Q3 2020 Nov 13, 2020	SELL	$95.51 - $112.95 $187,868 - $222,172	-1,967 Reduced 20.6%	7,583 $3.13 Million
Q2 2020 Aug 14, 2020	SELL	$62.68 - $105.34 $244,452 - $410,826	-3,900 Reduced 29.0%	9,550 $3.87 Million
Q1 2020 May 15, 2020	SELL	$47.79 - $75.63 $198,328 - $313,864	-4,150 Reduced 23.58%	13,450 $3.62 Million
Q4 2019 Feb 14, 2020	BUY	$36.62 - $57.29 $644,512 - $1.01 Million	17,600 New	17,600 $3.85 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Soleus Capital Management, L.P. with notifications on news.